Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Combination Lymphoma Immunotherapy Using Checkpoint Blockade and Intratumoral Virus-like Particles Containing CpG TLR9 Agonist

Caitlin D Lemke, PhD, Sue E Blackwell, MS, Arthur M Krieg, MD, Aliasger Salem, PhD, George J Weiner, MD

Blood (2016) 128 (22): 3023.

https://doi.org/10.1182/blood.V128.22.3023.3023

Published: 2016

Journal Articles

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

Patricia A. Taylor, Michael J. Ehrhardt, Christopher J. Lees, Angela Panoskaltsis-Mortari, Arthur M. Krieg, Arlene H. Sharpe, William J. Murphy, Jonathan S. Serody, Hiroaki Hemmi, Shizuo Akira, Robert B. Levy, Bruce R. Blazar

Blood (2008) 112 (8): 3508–3516.

https://doi.org/10.1182/blood-2007-09-113670

Published: 2008

Journal Articles

In Vivo CpG Administration Accelerates Graft-Versus-Host Disease (GVHD) Lethality by Toll-Like Receptor 9 (TLR9) Ligation of Host Antigen-Presenting Cells (APCs) and Promotes Allogeneic Bone Marrow (BM) Rejection by TLR9 Ligation of Donor APCs.

Bruce R. Blazar, Angela Panoskaltsis-Mortari, Arthur M. Krieg, Hiroaki Hemmi, Shizuo Akira, Jonathan Serody, William J. Murphy, Patricia A. Taylor

Blood (2006) 108 (11): 446.

https://doi.org/10.1182/blood.V108.11.446.446

Published: 2006

Journal Articles

Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses

Brenda J. Weigel, Narender Nath, Patricia A. Taylor, Angela Panoskaltsis-Mortari, Wei Chen, Arthur M. Krieg, Kenneth Brasel, Bruce R. Blazar

Blood (2002) 100 (12): 4169–4176.

https://doi.org/10.1182/blood-2002-04-1063

Published: 2002

Journal Articles

Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients

Bruce R. Blazar, Arthur M. Krieg, Patricia A. Taylor

Blood (2001) 98 (4): 1217–1225.

https://doi.org/10.1182/blood.V98.4.1217

Published: 2001

Journal Articles

Immunostimulatory CpG Oligodeoxynucleotides Enhance the Immune Response to Vaccine Strategies Involving Granulocyte-Macrophage Colony-Stimulating Factor

Hsin-Ming Liu, Sally E. Newbrough, Sudershan K. Bhatia, Christopher E. Dahle, Arthur M. Krieg, George J. Weiner

Blood (1998) 92 (10): 3730–3736.

https://doi.org/10.1182/blood.V92.10.3730

Published: 1998

Journal Articles

Immunostimulatory Oligodeoxynucleotides Containing CpG Motifs Enhance the Efficacy of Monoclonal Antibody Therapy of Lymphoma

James E. Wooldridge, Zuhair Ballas, Arthur M. Krieg, George J. Weiner

Blood (1997) 89 (8): 2994–2998.

https://doi.org/10.1182/blood.V89.8.2994

Published: 1997

NARROW

Combination Lymphoma Immunotherapy Using Checkpoint Blockade and Intratumoral Virus-like Particles Containing CpG TLR9 Agonist

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

In Vivo CpG Administration Accelerates Graft-Versus-Host Disease (GVHD) Lethality by Toll-Like Receptor 9 (TLR9) Ligation of Host Antigen-Presenting Cells (APCs) and Promotes Allogeneic Bone Marrow (BM) Rejection by TLR9 Ligation of Donor APCs.

Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses

Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients

Immunostimulatory CpG Oligodeoxynucleotides Enhance the Immune Response to Vaccine Strategies Involving Granulocyte-Macrophage Colony-Stimulating Factor

Immunostimulatory Oligodeoxynucleotides Containing CpG Motifs Enhance the Efficacy of Monoclonal Antibody Therapy of Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Combination Lymphoma Immunotherapy Using Checkpoint Blockade and Intratumoral Virus-like Particles Containing CpG TLR9 Agonist

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

In Vivo CpG Administration Accelerates Graft-Versus-Host Disease (GVHD) Lethality by Toll-Like Receptor 9 (TLR9) Ligation of Host Antigen-Presenting Cells (APCs) and Promotes Allogeneic Bone Marrow (BM) Rejection by TLR9 Ligation of Donor APCs.

Comparative analysis of murine marrow–derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses

Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients

Immunostimulatory CpG Oligodeoxynucleotides Enhance the Immune Response to Vaccine Strategies Involving Granulocyte-Macrophage Colony-Stimulating Factor

Immunostimulatory Oligodeoxynucleotides Containing CpG Motifs Enhance the Efficacy of Monoclonal Antibody Therapy of Lymphoma

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only